Q2 2026 Holdings
Filed 2026-08-14 | 16 holdings | $206.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $37.8M | 4,244,818 | 18.3% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $30.2M | 10,024,909 | 14.6% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $24.5M | 723,185 | 11.9% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $16.4M | 2,402,495 | 7.9% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $13.8M | 1,353,552 | 6.7% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $11.0M | 5,298,000 | 5.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $10.4M | 279,720 | 5.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $10.1M | 3,127,000 | 4.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $9.7M | 289,101 | 4.7% |
| Bausch Plus Lomb Corp(BLCO) | COMMON SHARES | 071705107 | $9.5M | 573,472 | 4.6% |
| Amgen Inc(AMGN) | COM | 031162100 | $7.3M | 20,212 | 3.5% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $7.3M | 132,500 | 3.5% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $6.0M | 136,000 | 2.9% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.9M | 43,300 | 2.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.8M | 126,985 | 2.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.0M | 28,587 | 1.5% |